CranioSense, Inc.
CranioSense, Inc. is a clinical stage medical device company developing a non invasive technology designed to support rapid assessment of intracranial hypertension at the point of care. Built for use by emergency care teams, the system integrates into the triage workflow, providing a quick and low risk screening tool to help identify patients who may require further diagnostic evaluation. By delivering actionable information within minutes without the need for invasive procedures or specialized expertise, CranioSense aims to improve triage, accelerate clinical decision making, and enhance patient outcomes in time critical neurological care.
Industries
Nr. of Employees
small (1-50)
CranioSense, Inc.
CranioSense, Inc. is currently seeking investment
CranioSense, Inc. is seeking a investment in the range of
Products
Non-invasive intracranial pressure assessment system (wearable patch + handheld reader)
A clinical-stage system that estimates intracranial pressure non-invasively using a forehead patch, clip-on sensors, and a handheld reader; intended for rapid triage and continuous monitoring without cranial penetration.
Non-invasive intracranial pressure assessment system (wearable patch + handheld reader)
A clinical-stage system that estimates intracranial pressure non-invasively using a forehead patch, clip-on sensors, and a handheld reader; intended for rapid triage and continuous monitoring without cranial penetration.
Expertise Areas
- Non-invasive intracranial pressure monitoring
- Clinical trial design and multi-site validation
- Diagnostic algorithm development and validation
- Wearable physiological sensor design
Key Technologies
- Pulse transit time (PTT)-based physiological analysis
- Near-infrared (NIR) signal algorithmics
- Wearable forehead sensor technology
- Portable/handheld monitoring device hardware
Key People
Investors
MedTech Innovator
Announced on 2024-05-29.
MassChallenge
Announced on 2023-07-26.
MedTech Innovator
Announced on 2024-05-29.
MassChallenge
Announced on 2023-07-26.
News & Updates
CranioSense has entered into a collaboration and licensing agreement with Vivonics Inc. to further develop and commercialize their IPASS technology.
CranioSense was recognized at the M2D2 2020 event.
CranioSense received recognition at the Tech Connect Innovation 2022 event.
CranioSense was acknowledged by TMC Innovation for their innovative solutions.
CranioSense participated in the MassChallenge program, highlighting their innovative approach.
CranioSense is part of the Northeastern Venture Mentoring Network, supporting their growth and innovation.
CranioSense has entered into a collaboration and licensing agreement with Vivonics Inc. to further develop and commercialize their IPASS technology.
CranioSense was recognized at the M2D2 2020 event.
CranioSense received recognition at the Tech Connect Innovation 2022 event.
CranioSense was acknowledged by TMC Innovation for their innovative solutions.
CranioSense participated in the MassChallenge program, highlighting their innovative approach.
CranioSense is part of the Northeastern Venture Mentoring Network, supporting their growth and innovation.